ACTG1 has been reported to be a causative gene for autosomal dominant sensorineural hearing loss, DFNA20/26. In this study we sought to clarify the detailed mutational spectrum, clinical features, and genotype-phenotype correlations.
Methods:
Massively parallel DNA sequencing (MPS) of 63 target candidate genes was used to screen 1120 Japanese hearing loss patients.
Results:
MPS screening successfully identified 4 ACTG1 mutations in 5 families. The majority of patients showed high frequency–involved progressive hearing loss, with the age of onset mostly in the first or second decade. One patient received electric acoustic stimulation (EAS), which showed a good outcome.
Conclusions:
Target exon-sequencing using MPS was proven to be a powerful new clinical diagnostic tool for the identification of rare causative genes such as ACTG1. The present clinical findings not only confirmed those previous reports but also provided important new clinical information.
MorellRJFridericiKHWeiSElfenbeinJLFriedmanTBFisherRA. A new locus for late-onset, progressive, hereditary hearing loss DFNA20 maps to 17q25. Genomics. 2000;63:1-6.
2.
ZhuMYangTWeiS, et al. Mutations in the gamma-actin gene (ACTG1) are associated with dominant progressive deafness (DFNA20/26). Am J Hum Genet. 2003;73:1082-1091.
3.
van WijkEKriegerEKempermanMH, et al. A mutation in the gamma actin 1 (ACTG1) gene causes autosomal dominant hearing loss (DFNA20/26). J Med Genet. 2003;40:879-884.
4.
MorínMBryanKEMayo-MerinoF, et al. In vivo and in vitro effects of two novel gamma-actin (ACTG1) mutations that cause DFNA20/26 hearing impairment. Hum Mol Genet. 2009;18:3075-3089.
5.
KhaitlinaSY. Functional specificity of actin isoforms. Int Rev Cytol. 2001;202:35-98.
6.
RendtorffNDZhuMFagerheimT, et al. A novel missense mutation in ACTG1 causes dominant deafness in a Norwegian DFNA20/26 family, but ACTG1 mutations are not frequent among families with hereditary hearing impairment. Eur J Hum Genet. 2006;14:1097-1105.
7.
LiuPLiHRenX, et al. Novel ACTG1 mutation causing autosomal dominant non-syndromic hearing impairment in a Chinese family. J Genet Genomics. 2008;35:553-558.
8.
MorínMBryanKEMayo-MerinoF, et al. In vivo and in vitro effects of two novel gamma-actin (ACTG1) mutations that cause DFNA20/26 hearing impairment. Hum Mol Genet. 2009;18:3075-3089.
9.
de HeerAMHuygenPLCollinRWOostrikJKremerHCremersCW. Audiometric and vestibular features in a second Dutch DFNA20/26 family with a novel mutation in ACTG1. Ann Otol Rhinol Laryngol. 2009;118:382-390.
10.
BaekJIOhSKKimDB, et al. Targeted massive parallel sequencing: the effective detection of novel causative mutations associated with hearing loss in small families. Orphanet J Rare Dis. 2012;7:60.
11.
ParkGGimJKimAR, et al. Multiphasic analysis of whole exome sequencing data identifies a novel mutation of ACTG1 in a nonsyndromic hearing loss family. BMC Genomics. 2013;14:191.
12.
MiyagawaMNishioSYIkedaTFukushimaKUsamiS. Massively parallel DNA sequencing successfully identifies new causative mutations in deafness genes in patients with cochlear implantation and EAS. PLoS One. 2013;8:e75793.
13.
MutaiHSuzukiNShimizuA, et al. Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross-sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis. 2013;8:172.
14.
VonaBMüllerTNandaI, et al. Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations. Genet Med. 2014;16:945-953.
15.
ChangXWangK. wANNOVAR; annotating genetic variants for personal genomes via the web. J Med Genet. 2012;49:433-436.
16.
WangKLiMHakonarsonH. ANNOVAR: functional annotation of genetic variation from high-throughput sequencing data. Nucleic Acid Res. 2010;38:e164.
17.
AbecasisGRAutonABrooksLD, et al. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491(7422):56-65.
NaraharaMHigasaKNakamuraS, et al. Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants. PLoS One2014;9(6):e100924.
20.
PollardKSHubiszMJRosenbloomKR, et al. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res. 2010;20(1):110-121.
21.
KumarPHenikoffSNgPC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4(7):1073-1081.
22.
AdzhubeiIASchmidtSPeshkinL, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248-249.
23.
ChunSFayJC. Identification of deleterious mutations within three human genomes. Genome Res. 2009;19(9):1553-1561.
24.
SchwarzJMRodelspergerCSchuelkeM, et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575-576.
25.
CooperGMStoneEAAsimenosG, et al. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res. 2005;15(7):901-913.
26.
Yin FooRGuppyMJohnstonLM. Intelligence assessments for children with cerebral palsy: a systematic review. Dev Med Child Neurol. 2013;55:911-918.
27.
Van CampGCouckePJAkitaJ, et al. A mutational hot spot in the KCNQ4 gene responsible for autosomal dominant hearing impairment. Hum Mutat. 2002;20:15-19.
28.
VandekerckhoveJWeberK. At least six different actins are expressed in a higher mammal: an analysis based on the amino acid sequence of the amino-terminal tryptic peptide. J Mol Biol. 1978;126:783-802.
29.
HöferDNessWDrenckhahnD. Sorting of actin isoforms in chicken auditory hair cells. J Cell Sci. 1997;110:765-770.
30.
LiHSHultcrantzM. Age-related degeneration of the organ of Corti in two genotypes of mice. ORL J Otorhinolaryngol Relat Spec. 1994;56:61-67.
31.
HuBHHendersonD. Changes in F-actin labeling in the outer hair cell and the Deiters cell in the chinchilla cochlea following noise exposure. Hear Res. 1997;110:209-218.
32.
BelyantsevaIAPerrinBJSonnemannKJ, et al. Gamma-actin is required for cytoskeletal maintenance but not development. Proc Natl Acad Sci U S A. 2009;106:9703-9708.
33.
RivièreJBvan BonBWHoischenA, et al. De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. Nat Genet. 2012;26;44(4):440-444, S1-S2.
34.
von IlbergCABaumannUKieferJTilleinJAdunkaOF. Electric acoustic stimulation of the auditory system: a review of the first decade. Audiol Neurootol. 2011;(suppl 2):1-30.
35.
UsamiSMiyagawaMNishioS, et al. Patients with CDH23 mutations and the 1555A>G mitochondrial mutation are good candidates for electric acoustic stimulation (EAS). Acta Otolaryngol. 2012;132:377-384.
